Tag

N. Ravi Kiran

1 article

Aurobindo Pharma CBO Emerging Markets Retires April 2026

Aurobindo Pharma discloses retirement of Mr. N. Ravi Kiran, Chief Business Officer for Emerging Markets, effective April 30, 2026. The disclosure is made pursuant to Regulation 30 of SEBI Listing Obli